Treatment with EGCG in NSCLC leads to decreasing interstitial fluid pressure and hypoxia to improve chemotherapy efficacy through rebalance of Ang-1 and Ang-2

Chinese Journal of Natural Medicines

Volumn 11, Issue 3, 2013, Pages 245-253

  Deng, Peng Bo ^a   Hu, Cheng Ping ^a   Xiong, Zeng ^a   Yang, Hua Ping ^a   Li, Yuan Yuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adjuvant chemotherapy; Angiopoietin 1; Angiopoietin 2; EGCG; Interstitial fluid pressure (IFP); Lung cancer; Tumor hypoxia; Tumor microenvironment

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CD31 ANTIGEN; CISPLATIN; EPIGALLOCATECHIN GALLATE; QUANTUM DOT;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CAPILLARY DENSITY; CONTROLLED STUDY; DOUBLE LABEL IMMUNOFLUORESCENCE; DRUG EFFICACY; FEMALE; HYPOXIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MICROVASCULARIZATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; TISSUE PRESSURE; TUMOR HYPOXIA; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT; WINK IN NEEDLE METHOD;

EID: 84878460362     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(13)60023-0     Document Type: Article

References (50)

1. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF [J]. Science 1999, 284(5422):1994-1998.
2. Holash J, Wiegand SJ, Yancopoulos GD New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF [J]. Oncogene 1999, 18(38):5356-5362.
3. Rodriguez SK, Guo W, Liu L, et al. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex [J]. Int J Cancer 2006, 118(7):1635-1644.
4. Shimizu M, Shirakami Y, Sakai H, et al. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells [J]. Chem Biol Interact 2010, 185(3):247-252.
5. Shapiro R, Vallee BL Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis [J]. Biochemistry 1989, 28(18):7401-7408.
6. Boucher Y, Kirkwood JM, Opacic D, et al. Interstitial hypertension in superficial metastatic melanomas in humans [J]. Cancer Res 1991, 51(24):6691-6694.
7. Raleigh JA, Chou SC, Arteel GE, et al. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors [J]. Radiat Res 1999, 151(5):580-589.
8. Rofstad EK, Halsor EF Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8 [J]. Br J Cancer 2002, 86(2):301-308.
9. Liu XL, Peng CW, Chen C, et al. Quantum dots-based double-color imaging of HER2 positive breast cancer invasion [J]. Biochem Biophys Res Commun 2011, 409(3):577-582.
10. Weidner N Intratumor microvessel density as a prognostic factor in cancer [J]. Am J Pathol 1995, 147(1):9-19.
11. Zhu BH, Zhan WH, Li ZR, et al. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis [J]. World J Gastroenterol 2007, 13(8):1162-1169.
12. Lai HC, Chao WT, Chen YT, et al. Effect of EGCG, a major component of green tea, on the expression of Ets-1, c-Fos, and c-Jun during angiogenesis in vitro [J]. Cancer Lett 2004, 213(2):181-188.
13. Oak MH, El BJ, Schini-Kerth VB Antiangiogenic properties of natural polyphenols from red wine and green tea [J]. J Nutr Biochem 2005, 16(1):1-8.
14. Sartippour MR, Heber D, ZhAng L, et al. Inhibition of fibroblast growth factors by green tea [J]. Int J Oncol 2002, 21(3):487-491.
15. Park JS, Kim MH, Chang HJ, et al. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2 [J]. Int J Oncol 2006, 29(5):1247-1252.
16. Shimizu M, Shirakami Y, Sakai H, et al. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells [J]. Chem Biol Interact 2010, 185(3):247-252.
17. Yamakawa S, Asai T, Uchida T, et al. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis [J]. Cancer Lett 2004, 210(1):47-55.
18. Ohga N, Hida K, Hida Y, et al. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells [J]. Cancer Sci 2009, 100(10):1963-1970.
19. Masuda M, Suzui M, Lim JT, et al. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction [J]. J Exp Ther Oncol 2002, 2(6):350-359.
20. Sachinidis A, Skach RA, Seul C, et al. Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins [J]. FASEB J 2002, 16(8):893-895.
21. Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J]. Cell 1996, 87(7):1161-1169.
22. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [J]. Science 1997, 277(5322):55-60.
23. Yu Q, Stamenkovic I Angiopoietin-2 is implicated in the regulation of tumor angiogenesis [J]. Am J Pathol 2001, 158(2):563-570.
24. Zhang L, Yang N, Park JW, et al. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer [J]. Cancer Res 2003, 63(12):3403-3412.
25. Oliner J, Min H, Leal J, et al. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 [J]. Cancer Cell 2004, 6(5):507-516.
26. Koga K, Todaka T, Morioka M, et al. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis [J]. Cancer Res 2001, 61(16):6248-6254.
27. Torimura T, Ueno T, Kin M, et al. Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma [J]. J Hepatol 2004, 40(5):799-807.
28. Takanami I Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis [J]. Oncol Rep 2004, 12(4):849-853.
29. Park JH, Park KJ, Kim YS, et al. Serum angiopoietin-2 as a clinical marker for lung cancer [J]. Chest 2007, 132(1):200-206.
30. Cai M, Zhang H, Hui R Single chain Fv antibody against angiopoietin-2 inhibits VEGF-induced endothelial cell proliferation and migration in vitro [J]. Biochem Biophys Res Commun 2003, 309(4):946-951.
31. Ley CD, Olsen MW, Lund EL, et al. Angiogenic synergy of bFGF and VEGF is antagonized by angiopoietin-2 in a modified in vivo Matrigel assay [J]. Microvasc Res 2004, 68(3):161-168.
32. Singh H, Milner CS, Aguilar HMM, et al. Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases [J]. Cell Signal 2009, 21(8):1346-1350.
33. Machein MR, Knedla A, Knoth R, et al. Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model [J]. Am J Pathol 2004, 165(5):1557-1570.
34. Nakayama T, Yao L, Tosato G Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors [J]. J Clin Invest 2004, 114(9):1317-1325.
35. Siddiqui IA, Malik A, Adhami VM, et al. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis [J]. Oncogene 2008, 27(14):2055-2063.
36. Chen SA, Chen HM, Yao YD, et al. Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products [J]. Eur J Pharm Sci 2012, 47(5):875-883.
37. Tait CR, Jones PF Angiopoietins in tumours: the angiogenic switch [J]. J Pathol 2004, 328(1):1-10.
38. Boucher Y, Jain RK Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse [J]. Cancer Res 1992, 52(18):5110-5114.
39. Netti PA, Hamberg LM, Babich JW, et al. Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules [J]. Proc Natl Acad Sci USA 1999, 96(6):3137-3142.
40. Ellingsen C, Hompland T, Mathiesen B, et al. Microenvironment-associated lymph node metastasis of human cervical carcinoma xenografts [J]. Acta Oncol 2012, 51(4):465-472.
41. Rofstad EK, Tunheim SH, Mathiesen B, et al. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts [J]. Cancer Res 2002, 62(3):661-664.
42. Machein MR, Knedla A, Knoth R, et al. Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model [J]. Am J Pathol 2004, 165(5):1557-1570.
43. Thurston G, Rudge JS, Ioffe E, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage [J]. Nat Med 2000, 6(4):460-463.
44. Kishimoto I, Rossi K, Garbers DL A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy [J]. Proc Natl Acad Sci USA 2001, 98(5):2703-2706.
45. Wu XH, Qian C, Yuan K Correlations of hypoxia-inducible factor-1alpha/hypoxia-inducible factor-2alpha expression with angiogenesis factors expression and prognosis in non-small cell lung cancer [J]. Chin Med J (Engl) 2011, 124(1):11-18.
46. Goudar RK, Vlahovic G Hypoxia, angiogenesis, and lung cancer [J]. Curr Oncol Rep 2008, 10(4):277-282.
47. Chou CW, Wang CC, Wu CP, et al. Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1 [J]. Neuro Oncol 2012, 14(10):1227-1238.
48. Dong XL, Xu PF, Miao C, et al. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1 [J]. Biomed Pharmacother 2012, 66(1):70-75.
49. Greijer AE, de Jong MC, Scheffer GL, et al. Hypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cells [J]. Cell Oncol 2005, 27(1):43-49.
50. Suganuma M, Saha A, Fujiki H New cancer treatment strategy using combination of green tea catechins and anticancer drugs [J]. Cancer Sci 2011, 102(2):317-323.